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1 Introduction 
With a prevalence of 13.1% chronic kidney disease (CKD) is 
one of the most common diseases in the United States [1]. 
Due to a failure of the kidneys, CKD patients suffer from an 
alteration of the blood serum electrolyte concentrations. 
Sodium, potassium and calcium influence the electrophysiol-
ogy of the heart. Therefore, patients suffering from CKD are 
at a higher risk to experience cardiovascular diseases (CVD). 
The death rate due to CVD is 10 to 30x higher in dialysis 
patients than in patients without CKD [2]. In order to study 
the relation between both diseases, the influence of a varia-
tion of the electrolyte concentrations on the cardiac signals 
needs to be investigated. Moreover, recent studies suggest a 
crucial role of hypocalcemia in the pathophysiology of brad-
ycardic sudden cardiac death in CKD patients [3]. El Sherif 
and Turito [4] report an action potential duration (APD) 
prolongation and a QT prolongation during hypocalcemia. 
However, in vivo studies are generally very limited, expen-
sive and associated with ethical issues, especially when per-
formed in humans. Therefore, computational cardiac model-
ling is a valuable complementary approach to investigate 
human cardiology. Pilia et al. [5], studied the feasibility of 
estimating calcium and potassium levels using simulated 
ECGs with the ten Tusscher et al. model. This model was 
able to realistically simulate alterations in extracellular potas-
sium concentration ([K+]o) on the AP and the ECG. When 
varying extracellular calcium concentrations ([Ca2+]o), how-
ever, the cell model did not show the results expected based 
on clinical findings, as APD and QT shortening was observed 
under hypocalcemic conditions. The reason is that the formu-
lation for the calcium-dependent inactivation of ICaL is not 
precise enough [6]. Summarizing, a computational model 
which is able to realistically reproduce the effects of serum 
calcium changes on the ECG is still lacking. 
Recently, Himeno et al. [7] presented a human ventricular 
cell model with refined calcium handling including calcium-
dependent inactivation of ICaL based on a spatially-resolved 
Markov formulation. In this work, we used their model to 
analyze the effects of serum calcium changes on cardiac 
action potentials (APs) and embedded it in a bi-ventricular 
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multi-scale model including a torso to study how the effects 
on the AP level translate to the body surface ECG.  
2 Methods 
In the original model presented by Himeno et al., the extra-
cellular sodium concentration ([Na+]o) was set to 140 mmol/l, 
[Ca2+]o to 1.8 mmol/l and [K+]o to 4.5 mmol/l. In this study, 
we varied one of the electrolyte concentrations per setup in 
the following ranges: 120 - 150 mmol/l [Na+]o, 0.6 - 3 mmol/l 
[Ca2+]o, 3 - 9 mmol/l [K+]o. As the ten Tusscher et al. model 
showed satisfactory results for [K+]o changes in [5] and 
changes due to [Na+]o variations were not pronounced, we 
present ventricular simulation results only for variation of 
[Ca2+]o, here. 
Single cell simulations were carried out to extract the AP 
curve by integrating gating variables with the Rush-Larsen 
method and the remaining differential equations with the 
forward Euler method. In order to evaluate the effect of an 
electrolyte variation on the AP, the following AP parameters 
were evaluated: amplitude, AP duration at 50% and 90% 
(APD50 and APD90), resting membrane voltage (RMV) and 
the maximum of the time derivative of the transmembrane 
voltage ([dVm/dt]max) describing the steepness of the AP 
upstroke. 
The initial state for tissue simulations was pre-calculated in a 
single cell environment to reach steady state conditions. We 
proposed reformulations of the Himeno et al. model to adapt 
it for tissue simulations by including apico-basal and trans-
mural heterogeneities as described in [8]. In this study, we 
worked with the original Himeno et al. model for simulations 
on cellular level and with the proposed reformulation of the 
model on tissue level. The excitation spread in the ventricles 
was simulated by solving the monodomain equation [9]. For 
each setup, a 12 lead ECG was computed. Since only ven-
tricular simulations were performed, the P-wave was not part 
of the simulated ECGs. 
As described in [5], transformed signals were calculated to 
combine information from all leads to one signal. 12 features 
were extracted from the transformed ECG signals to evaluate 
the effect of electrolyte changes. The literature generally 
describes QT segment prolongation during hypocalcemia and 
QT shortening during hypercalcemia. In this work, we ana-
lyzed the RT distance, as a variation of the QT segment di-
rectly implies a variation of the RT segment. Moreover, we 
evaluated the following features: peakedness and amplitude 
of the T wave, slope of the ascending (asc.) part and of the 
descending (desc.) part of the T wave, ratio of energy of the 
first half and of the second half of the T wave to the energy 
of the whole wave, amplitude of the R peak, energy of the R 
peak, ratio between the energy and the amplitude of the R 
peak (R ratio en./amp.), amplitude at 130 ms to evaluate ST 
elevation and QRS complex duration in lead Einthoven II. 
For further details regarding feature definition, the reader is 
referred to [5].  
3 Results 
3.1 Action Potential 
The results on the AP level are given in Table 1 and show 
that a variation of the electrolyte concentration affected al-
most all analyzed features. When decreasing an arbitrary 
ionic concentration, the ventricular model responded opposite 
than during an increase indicating monotonicity. An increase 
in [Na+]o resulted in an increase of amplitude, duration and 
upstroke slope of the AP and a decrease of the RMV. 
[dVm/dt]max showed the highest dependence on [Na+]o. Hy-
percalcemia mainly affected the AP by a reduction of the 
APD. However, a dependence of the upstroke slope and the 
amplitude was also observed, while the RMV remained un-
changed. A decrease of all feature values was observed dur-
ing an increase in [K+]o. The value showing the biggest 
changes during hyperkalemia was [dVm/dt]max and APD50 
during hypokalemia.  
3.2 ECG 
The effects of a [Ca2+]o variation on the analyzed ECG fea-
tures are shown in Table 2 and Figure 1. The results can be 
divided into three groups: features showing a high and a 
monotonous dependence on the [Ca2+]o concentration (RT 
distance, T amplitude, T asc. slope, T desc. slope, R ampli-
tude, R energy, R ratio en./amp. and ST elevation), features 
showing a high dependence (>4%) on [Ca2+]o and non-
monotonous relation (T ratio 1st half and T ratio 2nd half), 
features showing a low dependence on [Ca2+]o and non-mono-  
Table 1: Influence of concentration variation on features on cellu-
lar level. Values are given as percentage change with respect to 
the default ionic concentrations defined by Himeno et al. [7]. 
Conc. (mmol/l)/ 
Feature 
[Na+]o [Ca2+]o [K+]o 
120 150 0.6 3.0 3.0 9.0 
Amplitude −2.7 +1.3 −0.8 +0.9 +7.6 −18.3 
APD50 −1.8 +4.0 +24.0 −12.8 +14.2 −14.3 
APD90 −2.6 +0.8 +16.3 −7.7 +37.3 −22.9 
RMV +0.2 −0.1 0 0 +11.3 −20.1 
[dVm/dt]max −13.0 +9.8 +0.7 −0.6 +8.3 −84.6 
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Table 2: Influence of [Ca2+]o changes on features derived from simulated ECGs. Values are given as percentage change with respect to 
the default ionic concentration defined by Himeno et al. [7]. 
Conc. (mmol/l)/ 
Feature 0.6 1.0 1.4 2.2 2.6 3.0 
RT distance +23.31 +12.29 +5.08 −3.81 −7.20 −10.17 
T peakedness −3.42 +0.70 −2.62 −3.82 +1.94 +3.71 
T amplitude +12.01 +5.18 +1.16 −2.45 −5.47 −4.04 
T asc. slope +57.98 +30.17 +13.36 −7.70 −11.63 −15.96 
T desc. slope −32.73 −15.42 −4.00 +6.58 +11.22 +13.94 
T ratio 1st half −7.04 −1.71 +0.09 +0.83 +4.88 +2.44 
T ratio 2nd half +10.57 +2.29 −0.39 −1.21 −7.73 −3.75 
R amplitude -6.56 -3.86 −1.26 +0.98 +1.54 +2.45 
R energy -13.48 -8.15 −2.43 +1.84 +2.62 +4.57 
R ratio en./amp. -7.41 −4.46 −1.19 +0.85 +1.06 +2.07 
ST elevation −62.68 −38.94 −18.23 +15.81 +29.23 +40.58 
QRS duration 0 0 0 0 0 0 
tonous relation (T peakedness), and finally QRS duration 
which was invariant during hypo- and hypercalcemia. 
4 Discussion 
Clinical studies report that the main electrophysiological 
effect related to hypocalcemia is a prolongation of the APD 
[4]. Himeno et al. showed that their model is capable to re-
produce this effect. However, they only evaluated the results 
visually [7]. In this work, we studied the changes quantita-
tively and systematically by taking into account other fea-
tures and electrolytes ([Na+]o and [K+]o) as well. In our simu-
lations, [Na+]o affected all evaluated features slightly. An 
influence of the [Na+]o concentration on the amplitude and 
the slope of the upstroke has also been reported in [4]. A 
dependence of RMV on [Na+]o has not been reported in the 
literature to the best of our knowledge. As the [Na+]o  concen-
tration is taken into account in the Goldman-Hodgkin-Katz 
equation, we consider that an influence on the RMV plausi-
ble, though. APD prolongation was not reported either but we 
consider it realistic since an increase in the amplitude sug-
gests that the repolarization time is prolonged, too. 
[dVm/dt]max is the only value which showed a deviation > 5% 
with respect to the reference value. The absolute change was 
very small and almost not visible when analyzing the APs 
visually.  
When varying [K+]o, APD, RMV and [dVm/dt]max responded 
as expected from results described in literature [4].  
An alteration of [Ca2+]o was mainly observed in the APD. A 
decrease of APD is related to hypercalcemia according to 
clinical findings. AP amplitude and [dVm/dt]max showed a 
very small dependence on the alteration of [Ca2+]o (<1%). We 
presume that when using measured signals, these deviations 
will not be identifiable.  
On tissue level, the dependence of RT distance and ST eleva-
tion on [Ca2+]o was clearly visible in the ECGs (see Figure 1). 
These two changes due to an alteration in [Ca2+]o were also 
reported in the literature [4], [10]. T amplitude, T asc. slope, 
T desc. slope, R amplitude, R energy and R ratio en./amp. 
also showed a high dependence on [Ca2+]o changes. However, 
these features have not been evaluated in literature. We con-
sider these values relevant and suggest to take them into 
account in future studies. T peakedness showed deviations 
<4% with respect to the reference value. Thus, we consider it  
 
Figure 1: ECG lead II (Einthoven) for [Ca2+]o variation.  
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Figure 2: Comparison of simulated and clinical results from Gen-
ovesi et al. [11], Severi et al. [12] and Genovesi-Dossi et al. [13].  
 
less relevant for clinical scenarios using noisy measured 
signals.  
To evaluate our results, we compared the simulated RT 
shortening values due to [Ca2+]o changes with results from in 
vivo studies in patients (QTc dependence on [Ca2+]o). Our 
multi-scale simulator based on the Himeno et al. cellular 
model showed results within the same range as the results 
from Genovesi-Dossi et al. [13] and a comparable slope to 
[11], [12] (Figure 2). Summarizing, the evaluated results are 
in line with in vivo findings if these were reported in litera-
ture. We also showed the dependence of other features on 
electrolyte concentrations. Several limitations should be 
considered regarding this study: we computed ECGs based 
on the ventricular physiology and torso model of one healthy 
patient. Future studies could consider CKD-induced electro-
physiological remodeling and comprise a bigger number of 
virtual patients. Moreover, the influence of an electrolyte 
variation on the P wave was not analyzed as only ventricular 
simulations were performed. 
5 Conclusion  
Our multi-scale simulator realistically models the effects of 
[Na+]o, [Ca2+]o and [K+]o on the AP and how they translate to 
changes in the ECG. It additionally proves that the Himeno et 
al. model is capable of simulating realistic APs and ECGs at 
different extracellular ionic concentrations. This multi-scale 
simulator could help to understand the relation between CKD 
and cardiovascular diseases. The results can also be used for 
further studies based on the idea of considering the ECG as a 
non-invasive method to estimate the electrolyte concentra-
tions in the extracellular space [5], [14].  
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